BIOMAT Database Logo BIOMAT Database Logo

Tumour dormancy and clinical implications in breast cancer. 2013

L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Early Drug Development for Innovative Therapy Division, European Institute of Oncology, Milan, Italy.

The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients develop metastases many years after apparently successful treatment of their primary cancer. Tumour dormancy may explain the long time between initial diagnosis and treatment of cancer, and occurrence of relapse. The regulation of the switch from clinical dormancy to cancer regrowth in locoregional and distant sites is poorly understood. In this review, we report some data supporting the existence of various factors that may explain cancer dormancy including genetic and epigenetic changes, angiogenic switch, microenvironment, and immunosurveillance. A better definition and understanding of these factors should allow the identification of patients at high risk of relapse and to develop new therapeutic strategies in order to improve prognosis.

UI MeSH Term Description Entries

Related Publications

L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Tumour dormancy in breast cancer: an update.
January 2007, Breast cancer research : BCR,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
August 2001, Seminars in cancer biology,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Cancer micrometastasis and tumour dormancy.
January 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Implications for breast cancer dormancy in other areas of medicine.
January 2012, Breast cancer (Dove Medical Press),
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Dormancy and breast cancer.
March 1990, Journal of surgical oncology,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Dormancy in breast cancer.
December 2012, Breast cancer (Dove Medical Press),
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Dormancy in Breast Cancer.
November 2023, Cold Spring Harbor perspectives in medicine,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
The perivascular niche regulates breast tumour dormancy.
July 2013, Nature cell biology,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Progression and dormancy in metastatic thyroid cancer: concepts and clinical implications.
October 2020, Endocrine,
L Gelao, and C Criscitiello, and L Fumagalli, and M Locatelli, and S Manunta, and A Esposito, and I Minchella, and A Goldhirsch, and G Curigliano
Clinical opportunities and challenges in targeting tumour dormancy.
January 2013, Nature reviews. Clinical oncology,
Copied contents to your clipboard!